Advancing human health through science. We connect investors with therapeutics developers, medical device makers, diagnostics innovators, and digital health platforms improving outcomes worldwide.
Ageing populations, precision medicine, and the industrialisation of drug discovery are driving sustained investment across the life sciences. It is a sector where patient capital and deep domain expertise matter more than almost anywhere else.







.png)

Ageing populations, precision medicine, and the industrialisation of drug discovery are driving sustained investment across the life sciences. It is a sector where patient capital and deep domain expertise matter more than almost anywhere else.
.png)
.png)
.png)
.png)
.png)
GCN introduces healthcare and biotech founders to investors who understand trial timelines, regulatory risk, and long development cycles.
GCN introduces healthcare and biotech founders to investors who understand trial timelines, regulatory risk, and long development cycles.

Investor Reach

Connections Made

Cities

Countries Represented
.png)




